We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$257M
AUM Growth
+$5.27M
Cap. Flow
-$6.61M
Cap. Flow %
-2.58%
Top 10 Hldgs %
36.95%
Holding
105
New
4
Increased
18
Reduced
53
Closed
2

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$635K
2
XYL icon
Xylem
XYL
+$508K
3
GSK icon
GSK
GSK
+$464K
4
TGT icon
Target
TGT
+$358K
5
QCOM icon
Qualcomm
QCOM
+$332K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.79M
2
PEP icon
PepsiCo
PEP
+$2.28M
3
LH icon
Labcorp
LH
+$1.2M
4
XOM icon
ExxonMobil
XOM
+$451K
5
DE icon
Deere & Co
DE
+$294K

Sector Composition

Rank Sector Weight
1 Healthcare 22.63%
2 Technology 22.38%
3 Industrials 19%
4 Energy 13.93%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$635B
$12.5M 4.86%
119,062
-2,306
-2% -$233K
XOM icon
2
ExxonMobil
XOM
$651B
$11.7M 4.56%
116,071
-4,473
-4% -$451K
CNI icon
3
Canadian National Railway
CNI
$78.3B
$10.5M 4.1%
161,721
-4,040
-2% -$240K
CVS icon
4
CVS Health
CVS
$137B
$9.56M 3.73%
126,792
-1,875
-1% -$142K
NVS icon
5
Novartis
NVS
$295B
$9.1M 3.55%
112,120
-1,055
-0.9% -$83K
MMM icon
6
3M
MMM
$89B
$8.97M 3.5%
74,919
-2,499
-3% -$293K
PG icon
7
Procter & Gamble
PG
$343B
$8.72M 3.4%
110,992
-627
-0.6% -$50.6K
EMR icon
8
Emerson Electric
EMR
$82.9B
$7.99M 3.11%
120,338
-1,375
-1% -$92.4K
ADP icon
9
Automatic Data Processing
ADP
$100B
$7.6M 2.96%
109,268
-199
-0.2% -$13.6K
ATR icon
10
AptarGroup
ATR
$8.45B
$7.17M 2.8%
107,019
-640
-0.6% -$42.6K
INTC icon
11
Intel
INTC
$466B
$6.77M 2.64%
219,187
-4,425
-2% -$121K
SLB icon
12
SLB Ltd
SLB
$77.8B
$6.64M 2.59%
56,278
+775
+1% +$79.9K
EMC
13
DELISTED
EMC CORPORATION
EMC
$5.43M 2.12%
206,198
-500
-0.2% -$13.2K
CVX icon
14
Chevron
CVX
$388B
$5.35M 2.09%
41,015
-315
-0.8% -$39.2K
ORCL icon
15
Oracle
ORCL
$331B
$5.29M 2.06%
130,409
-1,300
-1% -$53.5K
MSFT icon
16
Microsoft
MSFT
$2.84T
$4.8M 1.87%
115,012
-1,300
-1% -$52.6K
QCOM icon
17
Qualcomm
QCOM
$176B
$4.73M 1.84%
59,670
+4,175
+8% +$332K
PEP icon
18
PepsiCo
PEP
$186B
$4.69M 1.83%
52,522
-26,450
-33% -$2.28M
MA icon
19
Mastercard
MA
$477B
$4.68M 1.82%
63,715
+2,345
+4% +$174K
AAPL icon
20
Apple
AAPL
$4.89T
$4.45M 1.73%
191,408
+1,736
+0.9% +$36.9K
HP icon
21
Helmerich & Payne
HP
$3.53B
$4.16M 1.62%
35,796
-570
-2% -$62.4K
ROK icon
22
Rockwell Automation
ROK
$51.4B
$4.06M 1.58%
32,409
+805
+3% +$99.2K
RTX icon
23
RTX Corp
RTX
$287B
$3.96M 1.54%
54,550
+1,565
+3% +$115K
JCI icon
24
Johnson Controls International
JCI
$87.5B
$3.66M 1.43%
69,930
+3,944
+6% +$196K
HD icon
25
Home Depot
HD
$332B
$3.54M 1.38%
43,672
-400
-0.9% -$31.6K

Similar funds

Kurt F. Somerville's Q2 2014 Portfolio in Review

As of Q2 2014, Kurt F. Somerville held 105 positions worth $257M, up 2.1% from $251M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kurt F. Somerville's Q2 2014 filing shows 4 new, 18 increased, 53 reduced and 2 closed positions. Its largest new stake was Xylem: 13,600 shares worth $530K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $2.79M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Kurt F. Somerville's largest Q2 2014 buy was Xylem: 13,600 shares worth $530K.
  • Kurt F. Somerville added most to Xilinx Inc in Q2 2014, an estimated $635K increase.
  • Kurt F. Somerville's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $2.79M.
  • Kurt F. Somerville fully exited Amgen in Q2 2014, selling an estimated $201K.
  • Kurt F. Somerville's ten largest holdings make up 37% of its $257M portfolio in Q2 2014.
  • Kurt F. Somerville opened 4 new positions and closed 2 in Q2 2014.
  • Kurt F. Somerville's portfolio value rose 2.1% quarter-over-quarter to $257M.

Based on Kurt F. Somerville's 13F filing for Q2 2014, filed 23 Jul 2014.